The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

1,640

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Schizophrenia
Interventions
DRUG

olanzapine-sertraline combination

the patient was prescribed low-dose olanzapine (7.5-10mg/day) combined with low-dose sertraline (50-100mg/day)

DRUG

only olanzapine

the patient was prescribed moderate to severity dose of olanzapine (12.5-20mg/day)

DRUG

risperidone-sertraline combination

the patient was prescribed low-dose risperidone (2-3.5mg/day) combined with low-dose sertraline (50-100mg/day)

DRUG

only risperidone

the patient was prescribed moderate to severity dose of risperidone (4-6mg/day)

DRUG

paliperidone-sertraline combination

the patient was prescribed low-dose paliperidone (3-4.5mg/day) combined with low-dose sertraline (50-100mg/day)

DRUG

only paliperidone

the patient was prescribed moderate to severity dose of paliperidone (6-9mg/day)

DRUG

ziprasidone-sertraline combination

the patient was prescribed low-dose ziprasidone (60-100mg/day) combined with low-dose sertraline (50-100mg/day)

DRUG

only ziprasidone

the patient was prescribed moderate to severity dose of ziprasidone (120-160mg/day)

All Listed Sponsors
lead

Beijing HuiLongGuan Hospital

OTHER

NCT04076371 - The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter